Researcher Computational Biology
Job description:
Next generation sequencing technologies are revolutionizing genetics by allowing us to sequence the genomes of many different individual organisms in a population and to observe their complex coding and non-coding transcriptomes and regulatory events under many conditions. Powerful genetic tools such as QTL mapping, large scale polymorphism libraries, RNAi and high content phenotyping allow the dissection of causal relationships.
These tasks create exciting opportunities for computational scientists to develop novel methods in statistics, signal processing and mathematical modeling. Our team of computational scientists, in the Genome Biology unit of the EMBL in Heidelberg, is tightly integrated in loops of experimentation, data analysis, model building, interpretation and refined experimentation.
Qualifications and experience:
The ideal candidate has a PhD in a quantitative or computational discipline; interest in multidisciplinary work covering statistics, mathematical modeling, genetics and molecular biology; competence in scientific computing and computer programming; interest in biology and its experimental technologies. A good publication record (which can include academic papers and scientific software) is expected. This position requires ability for teamwork, cross-discipline communication skills, reliability, attention to detail and effective time management. The working language is English.
Contact: whuberXXatXXembl.de
-
NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...10-30-2026, 06:46 AM -
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...10-14-2026, 09:55 AM